fda hiv - Search News

News

FDA approves HIV prevention drug taken

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

CBS News on MSN · 20h

FDA approves HIV prevention drug taken as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Yahoo · 5h

FDA approves new twice-yearly HIV prevention shot. Here's how it works

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

1hon MSN

FDA approves twice-yearly shot to prevent HIV

ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to approve the world’s only twice-a-year injectable form of PrEP.

23hon MSN

FDA Approves a Twice-Yearly Shot to Prevent HIV

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

8hon MSN

Revolutionary New Drug Offers 99.9% Protection Against HIV

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...

Fierce Pharma1d

FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results